Blume-Jensen Peter [Rocket]

Date	Name	Type	Security	Shares	Price	Value	Ownership	Reported
08/21/2023	Acrivon Therapeutics, Inc.	Grant	Common Stock	494k	$0.00	$0		08/21/2023
05/31/2023	Acrivon Therapeutics, Inc.	Exercise	Stock Option (Right to Buy)	33.6k	$3.88	$130.4k		05/31/2023
11/14/2022	Acrivon Therapeutics, Inc.	Grant	Common Stock	60.1k	$0.00	$0		11/14/2022
11/14/2022	Acrivon Therapeutics, Inc.	Grant	Common Stock	26.7k	$0.00	$0	See footnote	11/14/2022
11/14/2022	Acrivon Therapeutics, Inc.	Grant	Stock Option (Right to Buy)	180.3k	$12.50	$2.3M		11/14/2022
11/14/2022	Acrivon Therapeutics, Inc.	Grant	Stock Option (Right to Buy)	80.1k	$12.50	$1M	See footnote	11/14/2022
11/14/2022	Acrivon Therapeutics, Inc.	Grant	Common Stock	934.7k	$0.00	$0		11/14/2022
11/14/2022	Acrivon Therapeutics, Inc.	Grant	Common Stock	503.4k	$0.00	$0		11/14/2022